If you made any changes in Pure these will be visible here soon.

Research Output 2005 2019

Filter
Letter
2019

Interpreting the evidence from tolvaptan clinical trials

Tanaka, T., Kawana, M. & Kosaka, S., 2019 Aug 1, In : Journal of Cardiology. 74, 2, 1 p.

Research output: Contribution to journalLetter

Clinical Trials
tolvaptan
2018
1 Citation (Scopus)

Consequence of reimbursement policy alteration for urgent PCI in Japan

Ikemura, N., Sawano, M., Ueda, I., Fukuda, K. & Kosaka, S., 2018 Jun 2, In : The Lancet. 391, 10136, p. 2208-2209 2 p.

Research output: Contribution to journalLetter

Japan

The Case of Dynamic CHA2DS2-VASc Score: Beyond Risk Prediction

Sawano, M., Kohsaka, S., Kimura, T., Takatsuki, S. & Fukuda, K., 2018 May 1, In : Journal of the American College of Cardiology. 71, 17, 1 p.

Research output: Contribution to journalLetter

2017

Author's reply: Assessment of current use of guideline-based medical therapy in elderly patients with heart failure

West Tokyo Heart Failure Registry Investigators, 2017 Sep 1, In : International Journal of Cardiology. 242, p. 35 1 p.

Research output: Contribution to journalLetter

Heart Failure
Guidelines
Therapeutics

Declining risk of sudden death in heart failure

Sawano, M., Kosaka, S. & Fukuda, K., 2017 Nov 2, In : New England Journal of Medicine. 377, 18, 1 p.

Research output: Contribution to journalLetter

Sudden Death
Heart Failure
3 Citations (Scopus)
Vitamin K
Anticoagulants
Japan
2016

Effect of Pre-Procedural Beta-Blocker in Patients Undergoing Percutaneous Coronary Intervention

Maekawa, Y., Miyata, H., Ueda, I., Ikemura, N., Fukuda, K. & Kohsaka, S., 2016 Dec 12, In : JACC: Cardiovascular Interventions. 9, 23, p. 2458-2459 2 p.

Research output: Contribution to journalLetter

Percutaneous Coronary Intervention

Size Matters? Seeking High-Risk Populations Among “Normal” Individuals

Takei, M., Kohsaka, S., Fukuda, K. & Yoshikawa, T., 2016 Oct 1, In : JACC: Heart Failure. 4, 10, p. 828 1 p.

Research output: Contribution to journalLetter

Population
2015

Seasonal changes in systemic volume overload are to be considered

Mizuno, A., Kosaka, S., Shiraishi, Y., Goda, A. & Yoshikawa, T., 2015, In : Circulation Journal. 79, 3, p. 670 1 p.

Research output: Contribution to journalLetter

Heart Failure
Hypertension
2013

Challenges in retrospective analysis of PCI data in critically ill patients

Endo, A., Mizuno, A., Kosaka, S. & Ejiri, K., 2013 Sep, In : JACC: Cardiovascular Interventions. 6, 9, p. 986 1 p.

Research output: Contribution to journalLetter

Cardiogenic Shock
Percutaneous Coronary Intervention
Heart Arrest
Critical Illness
Resuscitation
2011

Elevated inflammatory markers in heart failure patients with lower BMI

Banno, A., Kosaka, S. & Yoshikawa, T., 2011 Mar, In : Journal of Cardiac Failure. 17, 3, p. 264 1 p.

Research output: Contribution to journalLetter

Disease Progression
Hospitalization
Body Mass Index
Heart Failure
2009

Authors' reply

Oshima, K., Kosaka, S., Koide, K. & Yoshikawa, T., 2009 Oct, In : Cardiology. 114, 4, p. 272 1 p.

Research output: Contribution to journalLetter

4 Citations (Scopus)

Reducing the dose of diuretics for heart failure patients: How low can it go?

Oshima, K., Kosaka, S., Koide, K. & Yoshikawa, T., 2009 Aug, In : Cardiology. 114, 2, p. 89 1 p.

Research output: Contribution to journalLetter

Drug Dose Response Relationship
Drug Administration Schedule
Age Factors
Diuretics
Japan
2005

Assessment of left ventricular mass using echocardiography: Use of fundamental imaging [2] (multiple letters)

Mansencal, N., Dubourg, O., Kosaka, S. & Di Tullio, M. R., 2005 May, In : American Heart Journal. 149, 5

Research output: Contribution to journalLetter

Left Ventricular Hypertrophy
Echocardiography
Electrocardiography
Stroke